Antibody-drug Conjugates Market: 2019-2022 Detailed Overview, Scope, Trends and Global Industry Growth Forecast Research Report

Worldwide Market Reports added Latest Research Report titled “Antibody-drug Conjugates Market by Manufacturers, Regions, Product Type and Application, Forecast to 2024” to its Large Report database.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
Scope of the Report:
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Takeda ranks the first in terms of revenue share in Global market of Antibody Drug Conjugate, occupies 54.17% of market share in 2016; While, Roche, with a market share of 35.11%, comes the second; The other companies consist of approximately 10.72% of the global market in 2016.
The worldwide market for Antibody-drug Conjugates is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antibody-drug Conjugates in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Get Sample Copy : https://www.worldwidemarketreports.com/sample/253590

Market Segment by Manufacturers, this report covers :
ImmunoGen
Seattle Genetics
Roche
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Adcetris
Kadcyla
Market Segment by Applications, can be divided into
Breast Cancer
Lymphoma

Table of Contents
1 Market Overview
2 Manufacturers Profiles
3 Global Antibody-drug Conjugates Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
4 Global Antibody-drug Conjugates Market Analysis by Regions
5 North America Antibody-drug Conjugates by Country
6 Europe Antibody-drug Conjugates by Country
7 Asia-Pacific Antibody-drug Conjugates by Country
8 South America Antibody-drug Conjugates by Country
9 Middle East and Africa Antibody-drug Conjugates by Countries
10 Global Antibody-drug Conjugates Market Segment by Type
11 Global Antibody-drug Conjugates Market Segment by Application
12 Antibody-drug Conjugates Market Forecast (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah

Worldwide Market Reports

Tel: +1 415 871 0703



Reset Password